Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.340
+0.050 (3.88%)
Aug 26, 2026, 12:31 PM EDT - Market open
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 112 employees as of December 31, 2025. The number of employees decreased by 22 or -16.42% compared to the previous year.
Employees
112
Change (1Y)
-22
Growth (1Y)
-16.42%
Revenue / Employee
n/a
Profits / Employee
-$602,027
Market Cap
138.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 112 | -22 | -16.42% |
| Dec 31, 2024 | 134 | 12 | 9.84% |
| Sep 30, 2024 | 127 | -8 | -5.93% |
| Jun 30, 2024 | 127 | -8 | -5.93% |
| Mar 31, 2024 | 122 | -62 | -33.70% |
| Dec 31, 2023 | 122 | -62 | -33.70% |
| Jun 30, 2023 | 135 | - | - |
| Dec 31, 2022 | 184 | -133 | -41.96% |
| Dec 31, 2021 | 317 | 55 | 20.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| Genelux | 26 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
INO News
- 9 days ago - Inovio reports Q2 EPS (7c) vs. (61c) last year - TheFly
- 9 days ago - Inovio upgraded to Buy from Hold at Jefferies - TheFly
- 13 days ago - Inovio Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Inovio Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 13 days ago - Inovio Pharmaceuticals Earnings release: Q2 2026 - Filings
- 13 days ago - Inovio Pharmaceuticals Slides: Q2 2026 - Filings
- 13 days ago - INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights - PRNewsWire
- 21 days ago - INOVIO to Report Second Quarter Financial Results on August 12, 2026 - PRNewsWire